Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lung Cancer, Nonsmall Cell, Recurrent”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00077311
What this trial is testing

Docetaxel and Cisplatin With or Without Dimesna in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
AnemiaDrug/Agent Toxicity by Tissue/OrganLung Cancer+1 more
Alliance for Clinical Trials in Oncology 160
Testing effectiveness (Phase 2)Looking for participantsNCT06051695
What this trial is testing

Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

Who this might be right for
Solid Tumor, AdultColorectal CancerNSCLC+17 more
A2 Biotherapeutics Inc. 474
Large-scale testing (Phase 3)Study completedNCT01285609
What this trial is testing

Phase 3 Trial in Squamous Non Small Cell Lung Cancer Subjects Comparing Ipilimumab Versus Placebo in Addition to Paclitaxel and Carboplatin

Who this might be right for
Lung Cancer - Non Small Cell Squamous
Bristol-Myers Squibb 1,289
Early research (Phase 1)Ended earlyNCT02309892
What this trial is testing

A Dose Escalation Study of L-DOS47 in Recurrent or Metastatic Non-Squamous NSCLC

Who this might be right for
Non-Small Cell Lung Cancer
Helix BioPharma Corporation 14
Testing effectiveness (Phase 2)Active Not RecruitingNCT02642042
What this trial is testing

Trametinib and Docetaxel in Treating Patients With Recurrent or Stage IV KRAS Mutation Positive Non-small Cell Lung Cancer

Who this might be right for
KRAS Gene MutationRecurrent Lung Non-Small Cell CarcinomaStage IV Lung Non-Small Cell Cancer AJCC v7
National Cancer Institute (NCI) 60
Early research (Phase 1)Study completedNCT00014066
What this trial is testing

Photodynamic Therapy Plus Brachytherapy in Treating Patients With Lung Cancer

Who this might be right for
Lung Cancer
Roswell Park Cancer Institute
Testing effectiveness (Phase 2)Study completedNCT00029003
What this trial is testing

Gefitinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Bronchoalveolar Cell Lung CancerRecurrent Non-small Cell Lung CancerStage IIIB Non-small Cell Lung Cancer+1 more
National Cancer Institute (NCI) 90
Testing effectiveness (Phase 2)Study completedNCT00096486
What this trial is testing

Gefitinib and Everolimus in Treating Patients With Stage IIIB or Stage IV or Recurrent Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Memorial Sloan Kettering Cancer Center 74
Testing effectiveness (Phase 2)Study completedNCT00006017
What this trial is testing

Two Rebeccamycin Analogue Regimens in Treating Patients With Advanced or Recurrent Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Case Comprehensive Cancer Center 42
Testing effectiveness (Phase 2)Study completedNCT00003062
What this trial is testing

Temozolomide in Patients With Progressive or Recurrent Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
European Organisation for Research and Treatment of Cancer - EORTC 70
Testing effectiveness (Phase 2)UnknownNCT03544723
What this trial is testing

Safety and Efficacy of p53 Gene Therapy Combined With Immune Checkpoint Inhibitors in Solid Tumors.

Who this might be right for
Solid TumorLymphoma
MultiVir, Inc. 40
Early research (Phase 1)Study completedNCT00667641
What this trial is testing

Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors

Who this might be right for
Breast CancerColorectal CancerHead and Neck Cancer+6 more
University of Medicine and Dentistry of New Jersey 16
Testing effectiveness (Phase 2)Study completedNCT01366131
What this trial is testing

Study Evaluating the Safety and Efficacy of MEGF0444A in Combination With Carboplatin, Paclitaxel and Bevacizumab in Patients With Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer Who Have Not Received Prior Chemotherapy for Advanced Disease (NILE)

Who this might be right for
Non-Squamous Non-Small Cell Lung Cancer
Genentech, Inc. 104
Large-scale testing (Phase 3)UnknownNCT00039039
What this trial is testing

Combination Chemotherapy Followed by Radiation Therapy With or Without Paclitaxel in Treating Patients With Unresectable Stage III Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy 300
Early research (Phase 1)Study completedNCT00072072
What this trial is testing

Celecoxib and Erlotinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Jonsson Comprehensive Cancer Center
Not applicableStudy completedNCT00900172
What this trial is testing

Study of Blood and Tissue Samples From Patients With Locally Advanced, Metastatic, or Recurrent Non-Small Cell Lung Cancer Treated With Bevacizumab, Carboplatin, and Paclitaxel

Who this might be right for
Lung Cancer
ECOG-ACRIN Cancer Research Group 180
Testing effectiveness (Phase 2)Study completedNCT00362882
What this trial is testing

Docetaxel and Bortezomib in Treating Patients With Progressive or Recurrent Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung CancerRecurrent Non-small Cell Lung CancerStage IV Non-small Cell Lung Cancer
National Cancer Institute (NCI) 81
Early research (Phase 1)Looking for participantsNCT07227168
What this trial is testing

STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer

Who this might be right for
Head and Neck Squamous Cell Carcinoma HNSCCNon-Small Cell Lung Cancer NSCLCEsophageal Cancer+6 more
Sutro Biopharma, Inc. 200
Large-scale testing (Phase 3)Study completedNCT01000025
What this trial is testing

PF-00299804 in Stage IIIB or Stage IV Non-Small Cell Lung Cancer Not Responding to Standard Therapy for Advanced or Metastatic Cancer

Who this might be right for
Lung Cancer
NCIC Clinical Trials Group 720
Testing effectiveness (Phase 2)Looking for participantsNCT07518160
What this trial is testing

JS212 Plus JS111 in EGFR-Mutant Advanced NSCLC: A Phase II Study

Who this might be right for
Locally Advanced, Metastatic, or Recurrent Non-small Cell Lung Cancer (NSCLC) Harboring Epidermal Growth Factor Receptor (EGFR) Mutations
Shanghai Junshi Bioscience Co., Ltd. 35
Next Page